224 related articles for article (PubMed ID: 26437222)
1. Cetuximab promotes epithelial to mesenchymal transition and cancer associated fibroblasts in patients with head and neck cancer.
Schmitz S; Bindea G; Albu RI; Mlecnik B; Machiels JP
Oncotarget; 2015 Oct; 6(33):34288-99. PubMed ID: 26437222
[TBL] [Abstract][Full Text] [Related]
2. Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma.
Cheng H; Fertig EJ; Ozawa H; Hatakeyama H; Howard JD; Perez J; Considine M; Thakar M; Ranaweera R; Krigsfeld G; Chung CH
Cancer Biol Ther; 2015; 16(8):1252-8. PubMed ID: 26046389
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia Mediates Differential Response to Anti-EGFR Therapy in HNSCC Cells.
Wiechec E; Hansson KT; Alexandersson L; Jönsson JI; Roberg K
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28468237
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of epithelial-mesenchymal transition by cetuximab via the EGFR-GEP100-Arf6-AMAP1 pathway in head and neck cancer.
Matsumoto Y; Sakurai H; Kogashiwa Y; Kimura T; Matsumoto Y; Shionome T; Asano M; Saito K; Kohno N
Head Neck; 2017 Mar; 39(3):476-485. PubMed ID: 27880014
[TBL] [Abstract][Full Text] [Related]
5. Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial.
Caponigro F; Di Gennaro E; Ionna F; Longo F; Aversa C; Pavone E; Maglione MG; Di Marzo M; Muto P; Cavalcanti E; Petrillo A; Sandomenico F; Maiolino P; D'Aniello R; Botti G; De Cecio R; Losito NS; Scala S; Trotta A; Zotti AI; Bruzzese F; Daponte A; Calogero E; Montano M; Pontone M; De Feo G; Perri F; Budillon A
BMC Cancer; 2016 Nov; 16(1):918. PubMed ID: 27884140
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-mesenchymal-transition induced by EGFR activation interferes with cell migration and response to irradiation and cetuximab in head and neck cancer cells.
Holz C; Niehr F; Boyko M; Hristozova T; Distel L; Budach V; Tinhofer I
Radiother Oncol; 2011 Oct; 101(1):158-64. PubMed ID: 21665310
[TBL] [Abstract][Full Text] [Related]
7. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
[TBL] [Abstract][Full Text] [Related]
8. Analysis of cancer-associated fibroblasts and the epithelial-mesenchymal transition in cutaneous basal cell carcinoma, squamous cell carcinoma, and malignant melanoma.
Sasaki K; Sugai T; Ishida K; Osakabe M; Amano H; Kimura H; Sakuraba M; Kashiwa K; Kobayashi S
Hum Pathol; 2018 Sep; 79():1-8. PubMed ID: 29555579
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts induce matrix metalloproteinase-mediated cetuximab resistance in head and neck squamous cell carcinoma cells.
Johansson AC; Ansell A; Jerhammar F; Lindh MB; Grénman R; Munck-Wikland E; Östman A; Roberg K
Mol Cancer Res; 2012 Sep; 10(9):1158-68. PubMed ID: 22809838
[TBL] [Abstract][Full Text] [Related]
10. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma.
Chen SF; Nieh S; Jao SW; Wu MZ; Liu CL; Chang YC; Lin YS
J Pathol; 2013 Oct; 231(2):180-9. PubMed ID: 23775566
[TBL] [Abstract][Full Text] [Related]
11. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
[TBL] [Abstract][Full Text] [Related]
12. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways.
Way TD; Huang JT; Chou CH; Huang CH; Yang MH; Ho CT
Eur J Cancer; 2014 Jan; 50(2):366-78. PubMed ID: 24157255
[TBL] [Abstract][Full Text] [Related]
13. Advanced Squamous Cell Carcinoma of the Head and Neck: The Current Role of Cetuximab.
Granados-García M; Aguilar-Ponce JL; Maldonado-Magos F; De la Garza-Salazar JG
ORL J Otorhinolaryngol Relat Spec; 2016; 78(6):320-333. PubMed ID: 28125819
[TBL] [Abstract][Full Text] [Related]
14. Anaplastic transition within the cancer microenvironment in early-stage oral tongue squamous cell carcinoma is associated with local recurrence.
Okuyama K; Suzuki K; Yanamoto S; Naruse T; Tsuchihashi H; Yamashita S; Umeda M
Int J Oncol; 2018 Oct; 53(4):1713-1720. PubMed ID: 30085337
[TBL] [Abstract][Full Text] [Related]
15. A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma.
Zhou B; Chen WL; Wang YY; Lin ZY; Zhang DM; Fan S; Li JS
J Oral Pathol Med; 2014 Sep; 43(8):585-92. PubMed ID: 24645915
[TBL] [Abstract][Full Text] [Related]
16. The relationship between EMT, CD44
Johansson AC; La Fleur L; Melissaridou S; Roberg K
J Oral Pathol Med; 2016 Oct; 45(9):640-646. PubMed ID: 26757432
[TBL] [Abstract][Full Text] [Related]
17. The upregulated α-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition.
Zhang Z; Yang XF; Huang KQ; Ren L; Zhao S; Gou WF; Shen DF; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2016 Feb; 37(2):1671-81. PubMed ID: 26311049
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody cetuximab impairs matrix metalloproteinases 2 and 9, epithelial-mesenchymal transition and cell migration in feline oral squamous cell carcinoma in vitro.
Altamura G; Martano M; Matrone A; Corteggio A; Borzacchiello G
Vet Comp Oncol; 2024 Mar; 22(1):149-155. PubMed ID: 38030131
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin Plus Cetuximab Inhibits Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Migration and Proliferation but Does Not Enhance Apoptosis.
Choi HS; Kim YK; Yun PY
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360933
[TBL] [Abstract][Full Text] [Related]
20. Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck.
Schmitz S; Hamoir M; Reychler H; Magremanne M; Weynand B; Lhommel R; Hanin FX; Duprez T; Michoux N; Rommel D; Lonneux M; Cappoen N; Gillain A; Machiels JP
Ann Oncol; 2013 Sep; 24(9):2261-6. PubMed ID: 23704200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
